🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/09/2007 | 48,50 | 49,36 | 47,82 | 49,20 | +1,96% | 3,17% | 12.927.290 |
| 18/09/2007 | 46,56 | 48,47 | 46,56 | 48,25 | +2,35% | 4,10% | 10.200.289 |
| 17/09/2007 | 46,99 | 47,38 | 46,73 | 47,15 | -0,26% | 1,38% | 7.201.646 |
| 14/09/2007 | 47,46 | 47,61 | 46,92 | 47,27 | -0,64% | 1,45% | 7.623.676 |
| 13/09/2007 | 48,19 | 48,55 | 47,34 | 47,58 | +0,38% | 2,51% | 12.863.047 |
| 12/09/2007 | 47,46 | 47,80 | 46,93 | 47,40 | -0,56% | 1,83% | 11.917.437 |
| 11/09/2007 | 47,81 | 47,93 | 47,24 | 47,66 | +0,28% | 1,44% | 8.005.986 |
| 10/09/2007 | 47,67 | 47,71 | 47,08 | 47,53 | +0,48% | 1,32% | 9.319.026 |
| 07/09/2007 | 47,90 | 48,57 | 47,19 | 47,30 | -1,78% | 2,89% | 12.171.891 |
| 06/09/2007 | 47,14 | 48,35 | 47,04 | 48,16 | +2,17% | 2,77% | 13.023.496 |
| 05/09/2007 | 47,27 | 47,42 | 46,78 | 47,14 | -1,28% | 1,35% | 8.506.616 |
| 04/09/2007 | 48,18 | 48,18 | 47,36 | 47,75 | -0,26% | 1,70% | 10.004.418 |
| 31/08/2007 | 47,75 | 48,19 | 47,61 | 47,87 | +1,03% | 1,22% | 7.681.002 |
| 30/08/2007 | 47,17 | 47,80 | 47,00 | 47,39 | -0,52% | 1,68% | 7.698.818 |
| 29/08/2007 | 46,97 | 47,71 | 46,50 | 47,63 | +1,44% | 2,58% | 6.599.046 |
| 28/08/2007 | 47,55 | 47,80 | 46,86 | 46,96 | -1,82% | 1,97% | 8.198.294 |
| 27/08/2007 | 48,52 | 48,61 | 47,71 | 47,82 | -1,38% | 1,85% | 8.010.388 |
| 24/08/2007 | 48,19 | 48,53 | 47,80 | 48,49 | +0,63% | 1,52% | 7.490.475 |
| 23/08/2007 | 48,39 | 48,42 | 47,67 | 48,19 | +0,28% | 1,54% | 10.289.264 |
| 22/08/2007 | 47,97 | 48,44 | 47,35 | 48,05 | +1,19% | 2,27% | 11.241.162 |
| 21/08/2007 | 47,73 | 48,21 | 46,51 | 47,49 | -0,42% | 3,56% | 8.716.530 |
| 20/08/2007 | 47,35 | 48,65 | 47,12 | 47,69 | +0,73% | 3,24% | 8.505.463 |
| 17/08/2007 | 47,79 | 47,96 | 46,37 | 47,35 | +0,32% | 3,31% | 17.209.942 |
| 16/08/2007 | 47,33 | 47,68 | 45,91 | 47,19 | -0,64% | 3,75% | 21.263.396 |
| 15/08/2007 | 47,76 | 48,28 | 47,13 | 47,50 | -0,30% | 2,42% | 10.967.320 |
| 14/08/2007 | 48,24 | 48,42 | 47,57 | 47,64 | -1,25% | 1,76% | 8.880.438 |
| 13/08/2007 | 48,10 | 49,24 | 48,10 | 48,24 | -0,63% | 2,36% | 8.458.513 |
| 10/08/2007 | 49,08 | 49,33 | 47,76 | 48,55 | -1,09% | 3,21% | 16.039.430 |
| 09/08/2007 | 49,22 | 50,10 | 47,95 | 49,08 | -1,76% | 4,36% | 15.497.510 |
| 08/08/2007 | 49,78 | 50,32 | 48,59 | 49,96 | +1,41% | 3,49% | 11.980.526 |